Cardiologist and AF discoverer at Danderyd Hospital
Stockholm
Joined January 2020
- Tweets49
- Following30
- Followers50
- Likes17
We are proudly looking forward to the presentation of the STROKESTOP 2 study by Katrin Kemp Gudmundsdottir on sunday september 1st, #ESCCongress hotline 9. Many thanks to the 6868 participants from the Stockholm region and Roche Diagnostics for inspiring collaboration.
4
118
Happy to invite all interested in the future of heart rhythm monitoring to Dr Jonatan Fernstads presentation on large-scale data of machine learning reading of smartphone PPG, ESC congress Saturday 31st at Science Box 2 - Research Gateway.
lnkd.in/dsRDpdex
#ESCCongress
2
35
Validation of a novel smartphone-based photoplethysmographic method for ambulatory heart rhythm diagnostics academic.oup.com/europace/ar…
Heart rhythm recording using smartphone photopletysmography (PPG) has an enormous potential given the device availability.
2
60
Johan Engdahl retweeted
Presented at #ACC24:
Hospitalized patients with acute myocardial infarction & preserved EF were assigned to receive open-label long-term beta-blocker therapy or not. Beta-blockers did not lead to a lower risk of death or MI. Full REDUCE-AMI trial results: nej.md/4akVhRx
ALT Graph showing death from any cause or new myocardial infarction (primary end point)
Johan Engdahl retweeted
For you interested in AFib and rhythm-versus-rate control:
Hold the date of the public scientific defense of dr. Marita K. Pope, our MD-PhD-candidate.
April 22nd, 2024.
Trial Lecture at 10:15 and defense at 13:15.
‘Gamle Festsal’ of the University of Oslo, next to the Aula. – at Oslo, Norway
ahajournals.org/doi/10.1161/…
Very well formulated editorial by Lars Wallentin and Robert Giugliano on the FRAIL AF study!
1
56
ISC 2024: Data from STROKE AF study show cost effectiveness of ICM in ischaemic stroke patients cardiacrhythmnews.com/stroke… I believe this cost effectiveness analysis would have been strengthened with outcomes.
Randomised, siteless study to compare systematic atrial fibrillation screening using enrichment by a risk prediction model with standard care in a Swedish population aged ≥ 65 years: CONSIDERING-AF study design @BMJ_Open bmjopen.bmj.com/content/14/1…
1
45
Finally, we publish the study design of the secondary preventive AF screening study AF SPICE! Study commenced inclusion in january 2022. Nice to hear any comments from you. bmjopen.bmj.com/content/13/1…
6
217
Johan Engdahl retweeted
BREAKING
OCEANIC-AF study stopped early due to lack of efficacy
Independent Data Monitoring Committee (IDMC) recommends stopping the OCEANIC-AF study due to inferior efficacy of #asundexian vs apixaban in atrial fibrillation bayer.com/media/en-us/oceani…
Amazing PhD defense from Anna Thorén at Danderyds Hospital today, with her Thesis on Prediction and Monitoring of in-hospital cardiac arrest. Many congrats!
1
39
Johan Engdahl retweeted
With @ARTESIA_RCT presented at #AHA23 this AM, many are working to reconcile the positive results with those from NOAH @afnet_ev 6 from #ESC2023. This meta-analysis does just that. The trials are totally consistent: ahajournals.org/doi/10.1161/… #EPeeps
What Lies beneath the Surface — Treatment of Subclinical Atrial Fibrillation | NEJM www-nejm-org.proxy.kib.ki.se…
You have to read the Artesia editorial by @EmmaSvennberg !
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation | NEJM Amazing results from Artesia. nejm.org/doi/full/10.1056/NE…
afspice.com/
Passing 900 randomized patients in AF SPICE, on a path towards less knowledge gaps in ECG screening post stroke.
Oral Anticoagulation in ICH Patients With AF: New Data medscape.com/viewarticle/997… via @medscape
1
34
Rapid response team activation prior to in-hospital cardiac arrest: Areas for improvements based on a national cohort study - Resuscitation resuscitationjournal.com/art…
K
38